NEWS

Discover:

World Diabetes Day 2025 - Let's focus on our ongoing research this past year.

By Claire MASALSKI • November 14, 2025

November 14, 2025

PhD Thesis at CeeD: Impact of exerkines in adipocyte functions and their implication in adipose tissue – pancreas crosstalk in a context of type 2 diabetes.

By Claire MASALSKI • October 28, 2025

October 29 2025

PhD Thesis at CeeD: Study of the impact of extracellular vesicles in the process of Human pancreatic islet transplantation

By Claire MASALSKI • October 10, 2025

October 10 2025

New postdoc on the benefits of resistance training upon beta-cells and the molecules involved in this process

By Claire MASALSKI • September 16, 2025

September 1 2025

New publication on Exerkines: a review of Physical Exercise as a Therapeutic Approach for Type 2 Diabetes

By Claire MASALSKI • September 2, 2025

August 25 2025

Scientific sessions of the American Diabetes Association (ADA) 2025 in Chicago, USA

By Claire MASALSKI • June 24, 2025

June 20-23 2025

Dr Jean-Baptiste POTIER successfully defended his PhD thesis on myokine ILV001, MASLD and MASH

PhD Thesis at CeeD: Impact of the myokine ILV001 on MASLD and MASH

By Claire MASALSKI • June 10, 2025

June 16 2025

Société Francophone du Diabète (SFD) 2025 in Paris, FR

By Claire MASALSKI • April 3, 2025

April 1-4 2025

New publication on DECORIN, a triceps-derived myokine, and type 2 diabetes on Acta Physiol (Oxf)

By Claire MASALSKI • January 30, 2025

January 30 2025

Happy new year 2025

By Claire MASALSKI • January 7, 2025

CeeD, Vaincre le diabète, and its spin-off, Ilonov and CEED Formation, wish you a happy new year. A little touch of humor to start 2025… This year, we asked AI to generate our greeting card. Our instructions: represent our fight against diabetes and carry a message of hope, unity and innovation. According to the tool, this scene would harmoniously illustrate research, patient care and health professionals training. We let you judge the result 😉 Thank you for your support and your generosity.